The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

US Transthyretin Amyloidosis Treatment Market Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The U.S. transthyretin a ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Regulators in the EU, China, and Japan have started reviews of GSK's depemokimab, aiming to become the first drug for severe asthma that can be given just twice a year. The EMA and counterparts in ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Amongst the APEC countries and regions in the survey, hospitalisation costs per older adult in Singapore amounted to SGD ...

GSK is paying $66 million upfront to license ... $66 million upfront for rights to tebipenem in all regions, except Japan and some other Asian countries – where rights are held by Meiji Seika ...